Spanish Red Biotech Pipeline

Oryzon

Vafidemstat (ORY-2001) - CNS optimized LSD1 inhibitor

Type: Biodrugs/ Drugs
Therapeutic area:
Indication: SetD1A Compass related SCZ New Clinical Trial - Under study
Phase: 2Phase II, 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical